Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.
--------
3:45
Neuroimmunology Update 2025: MOGAD Treatments
Dr. Justin Abbatemarco discusses updates around MOGAD treatments. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964 https://jnnp.bmj.com/content/95/11/1054
Dr. Justin Abbatemarco discusses autoimmune encephalitis with a focus on outcomes. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000210109 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract
--------
2:45
The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
Dr. Halley Alexander discusses the Neurology Today article, “The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
--------
3:06
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Dr. Greg Cooper and Dr. Joseph Therriault discuss the use of plasma biomarkers in diagnosing Alzheimer disease. Show reference: https://doi.org/10.1038/s43587-024-00731-y
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Australia